Frequency of p53 mutations in hepatocellular carcinomas from atomic bomb survivors

Journal of the National Cancer Institute

Volumn 90, Issue 15, 1998, Pages 1167-

  Iwamoto, Keisuke S ^a   Mizuno, Terumi ^a   Tokuoka, Shoji ^b   Mabuchi, Kiyohiko ^b   Seyama, Toshio ^a,b  

^a Department of Radiobiology ^*  (Japan)

^b RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; ATOMIC BOMB SURVIVOR; CANCER GENETICS; DNA DETERMINATION; GENE MUTATION; HUMAN; LIVER CELL CARCINOMA; STATISTICAL ANALYSIS;

EID: 17144467701     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.15.1167     Document Type: Article

References (13)

1. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. NIH conference, Hepatocellular carcinoma. Ann Intern Med 1988;108:390-401.
2. Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991;51:2842-7.
3. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S. p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res 1992; 52:6358-64.
4. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, et al. Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987 [published erratum appears in Radiat Res 1994;139:129]. Radiat Res 1994;137(2 Suppl):S17-S67.
5. Iwamoto KS, Mizuno T, Ito T, Akiyama M, Takeichi N, Mabuchi K, et al. Feasibility of using decades-old archival tissues in molecular oncology/epidemiology. Am J Pathol 1996;149:399-406.
6. Livni N, Eid A, Ilan Y, Rivkind A, Rosenmann E, Blendis LM, et al. p53 expression in patients with cirrhosis with and without hepatocellular carcinoma. Cancer 1995;75: 2420-6.
7. Kishimoto Y, Shiota G, Kamisaki Y, Wada K, Nakamoto K, Yamawaki M, et al. Loss of the minor suppressor p53 gene at the liver cirrhosis stage in Japanese patients with hepatocellular carcinoma. Oncology 1997;54: 304-10.
8. Iwamoto KS, Mizuno T, Kurata A, Masuzawa M, Mori T, Seyama T. Multiple, unique and comon p53 mutations in a thorotrast recipient with four primary cancers. Hum Pathol 1998;29:412-6.
9. Hully JR, Su Y, Lohse JK, Griep AK, Sattler CA, Haas MJ, et al. Transgenic hepatocarcinogenesis in the rat. Am J Pathol 1994;145: 386-97.
10. Goodhead DT. Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. Int J Radiat Biol 1994;65:7-17.
11. Cha RS, Thilly WG, Zarbl H. N-Nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations. Proc Natl Acad Sci U S A 1994;91:3749-53.
12. Yin L, Ghebranious N, Chakraborty S, Sheehan CE, Ilic Z, Sell S. Control of mouse hepatocyte proliferation and ploidy by p53 and p53ser246 mutation in vivo. Hepatology 1998;27:73-80.
13. Cha RS, Guerra L, Thilly WG, Zarbl H. Haras-1 oncogene mutations in mammary epithelial cells do not contribute to initiation of spontaneous mammary tumorigenesis in rats. Carcinogenesis 1996;17:2519-24.